Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. European Lung Cancer Congress 2025

ESTRO: How IO can change classical therapeutic approaches in SCLC?

What is the role of brain RT in IO era (PCI, WBRT, SRS)

Date

28 Mar 2025

Session

ESTRO: How IO can change classical therapeutic approaches in SCLC?

Topics

Cytotoxic Therapy;  Radiation Oncology

Tumour Site

Small Cell Lung Cancer

Presenters

Cécile Le Pechoux

Authors

C. Le Pechoux

Author affiliations

  • Institut Gustave Roussy, Villejuif/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: ESTRO: How IO can change classical therapeutic approaches in SCLC?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.